Fanelli F et al. |
Plasma 2-arachidonoylglycerol is a biomarker of age and menopause related insulin resistance and dyslipidemia in lean but not in obese men and women. |
2017 |
Mol Metab |
pmid:28462075
|
Knani I et al. |
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome. |
2016 |
Mol Metab |
pmid:27900261
|
Banni S and Di Marzo V |
Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood. |
2010 |
Mol Nutr Food Res |
pmid:20013888
|
Rajaraman G et al. |
G protein coupled receptor 18: A potential role for endocannabinoid signaling in metabolic dysfunction. |
2016 |
Mol Nutr Food Res |
pmid:26337420
|
Guasti L et al. |
Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain. |
2009 |
Mol Pain |
pmid:19570201
|
Higgins A et al. |
Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids. |
2013 |
Mol Pain |
pmid:23725095
|
González-Mariscal I et al. |
Blockade of cannabinoid 1 receptor improves GLP-1R mediated insulin secretion in mice. |
2016 |
Mol. Cell. Endocrinol. |
pmid:26724516
|
Battista N et al. |
The role of endocannabinoids in gonadal function and fertility along the evolutionary axis. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22305972
|
Szekeres M et al. |
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signaling-induced vasoconstriction and hypertension. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25595485
|
Costa MA et al. |
2-Arachidonoylglycerol impairs human cytotrophoblast cells syncytialization: influence of endocannabinoid signalling in placental development. |
2015 |
Mol. Cell. Endocrinol. |
pmid:25199616
|
Oláh M et al. |
The role of endocannabinoids in the regulation of luteinizing hormone and prolactin release. Differences between the effects of AEA and 2AG. |
2008 |
Mol. Cell. Endocrinol. |
pmid:18308464
|
Gyombolai P et al. |
Regulation of endocannabinoid release by G proteins: a paracrine mechanism of G protein-coupled receptor action. |
2012 |
Mol. Cell. Endocrinol. |
pmid:22075205
|
Catanzaro G et al. |
Effect of capacitation on the endocannabinoid system of mouse sperm. |
2011 |
Mol. Cell. Endocrinol. |
pmid:21723369
|
Xu C et al. |
Endocannabinoids exert CB receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein. |
2017 |
Mol. Cell. Neurosci. |
pmid:28733129
|
Fezza F et al. |
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. |
2014 |
Mol. Cell. Neurosci. |
pmid:25064144
|
Krishnan G and Chatterjee N |
Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity. |
2014 |
Mol. Cell. Neurosci. |
pmid:24418364
|
Maccarrone M et al. |
Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility. |
2005 |
Mol. Hum. Reprod. |
pmid:15563449
|
Patsenker E et al. |
Cannabinoid receptor type I modulates alcohol-induced liver fibrosis. |
2011 |
Mol. Med. |
pmid:21863215
|
van der Stelt M et al. |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system. |
2002 Oct-Dec |
Mol. Neurobiol. |
pmid:12428763
|
Luchicchi A and Pistis M |
Anandamide and 2-arachidonoylglycerol: pharmacological properties, functional features, and emerging specificities of the two major endocannabinoids. |
2012 |
Mol. Neurobiol. |
pmid:22801993
|
Rockwell CE et al. |
Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2. |
2006 |
Mol. Pharmacol. |
pmid:16611855
|
Raman P et al. |
15-Deoxy-delta12,14-prostaglandin J2-glycerol ester, a putative metabolite of 2-arachidonyl glycerol, activates peroxisome proliferator activated receptor gamma. |
2011 |
Mol. Pharmacol. |
pmid:21511917
|
Yates ML and Barker EL |
Inactivation and biotransformation of the endogenous cannabinoids anandamide and 2-arachidonoylglycerol. |
2009 |
Mol. Pharmacol. |
pmid:19389920
|
Jung KM et al. |
A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. |
2007 |
Mol. Pharmacol. |
pmid:17584991
|
Jäntti MH et al. |
Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling. |
2013 |
Mol. Pharmacol. |
pmid:23233488
|
Dinh TP et al. |
RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. |
2004 |
Mol. Pharmacol. |
pmid:15272052
|
He F et al. |
Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor. |
2007 |
Mol. Pharmacol. |
pmid:17698952
|
Jain T et al. |
Diacylglycerol lipaseα (DAGLα) and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. |
2013 |
Mol. Pharmacol. |
pmid:23748223
|
Lichtman AH et al. |
Endocannabinoid overload. |
2010 |
Mol. Pharmacol. |
pmid:20952498
|
Gonsiorek W et al. |
Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide. |
2000 |
Mol. Pharmacol. |
pmid:10779390
|
Carrier EJ et al. |
Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism. |
2004 |
Mol. Pharmacol. |
pmid:15044630
|
Laitinen T et al. |
Mutation of Cys242 of human monoacylglycerol lipase disrupts balanced hydrolysis of 1- and 2-monoacylglycerols and selectively impairs inhibitor potency. |
2014 |
Mol. Pharmacol. |
pmid:24368842
|
Jung KM et al. |
Stimulation of endocannabinoid formation in brain slice cultures through activation of group I metabotropic glutamate receptors. |
2005 |
Mol. Pharmacol. |
pmid:16051747
|
Straiker A et al. |
Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. |
2009 |
Mol. Pharmacol. |
pmid:19767452
|
Ouyang Y et al. |
Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells. |
1998 |
Mol. Pharmacol. |
pmid:9547358
|
Guo J and Ikeda SR |
Endocannabinoids modulate N-type calcium channels and G-protein-coupled inwardly rectifying potassium channels via CB1 cannabinoid receptors heterologously expressed in mammalian neurons. |
2004 |
Mol. Pharmacol. |
pmid:14978245
|
Delgado-Peraza F et al. |
Mechanisms of Biased β-Arrestin-Mediated Signaling Downstream from the Cannabinoid 1 Receptor. |
2016 |
Mol. Pharmacol. |
pmid:27009233
|
Neumeister A et al. |
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. |
2013 |
Mol. Psychiatry |
pmid:23670490
|
Muccioli GG et al. |
The endocannabinoid system links gut microbiota to adipogenesis. |
2010 |
Mol. Syst. Biol. |
pmid:20664638
|
Fezza F et al. |
Endocannabinoids, related compounds and their metabolic routes. |
2014 |
Molecules |
pmid:25347455
|
Szafran BN et al. |
Characterization of Endocannabinoid-Metabolizing Enzymes in Human Peripheral Blood Mononuclear Cells under Inflammatory Conditions. |
2018 |
Molecules |
pmid:30513753
|
Flores-Otero J et al. |
Ligand-specific endocytic dwell times control functional selectivity of the cannabinoid receptor 1. |
2014 |
Nat Commun |
pmid:25081814
|
Bluett RJ et al. |
Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. |
2017 |
Nat Commun |
pmid:28348378
|
Tung LW et al. |
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid-mediated disinhibition of dopaminergic neurons. |
2016 |
Nat Commun |
pmid:27448020
|
Jung KM et al. |
Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. |
2012 |
Nat Commun |
pmid:23011134
|
Alpár A et al. |
Endocannabinoids modulate cortical development by configuring Slit2/Robo1 signalling. |
2014 |
Nat Commun |
pmid:25030704
|
Iannotti FA et al. |
Genetic and pharmacological regulation of the endocannabinoid CB1 receptor in Duchenne muscular dystrophy. |
2018 |
Nat Commun |
pmid:30262909
|
Duggan KC et al. |
(R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. |
2011 |
Nat. Chem. Biol. |
pmid:22053353
|
Hsu KL et al. |
DAGLβ inhibition perturbs a lipid network involved in macrophage inflammatory responses. |
2012 |
Nat. Chem. Biol. |
pmid:23103940
|
Nomura DK et al. |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
2008 |
Nat. Chem. Biol. |
pmid:18438404
|
Long JZ et al. |
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. |
2009 |
Nat. Chem. Biol. |
pmid:19029917
|
Kim J and Alger BE |
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. |
2004 |
Nat. Neurosci. |
pmid:15184902
|
Lourenço J et al. |
Synaptic activation of kainate receptors gates presynaptic CB(1) signaling at GABAergic synapses. |
2010 |
Nat. Neurosci. |
pmid:20081851
|
Puente N et al. |
Polymodal activation of the endocannabinoid system in the extended amygdala. |
2011 |
Nat. Neurosci. |
pmid:22057189
|
Self DW |
Anandamide: a candidate neurotransmitter heads for the big leagues. |
1999 |
Nat. Neurosci. |
pmid:10204533
|
Giuffrida A et al. |
Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. |
1999 |
Nat. Neurosci. |
pmid:10204543
|
Shonesy BC et al. |
CaMKII regulates diacylglycerol lipase-α and striatal endocannabinoid signaling. |
2013 |
Nat. Neurosci. |
pmid:23502535
|
Kim J and Alger BE |
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. |
2010 |
Nat. Neurosci. |
pmid:20348918
|
Maccarrone M et al. |
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. |
2008 |
Nat. Neurosci. |
pmid:18204441
|
Di Marzo V |
Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. |
2011 |
Nat. Neurosci. |
pmid:21187849
|
Makara JK et al. |
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus. |
2005 |
Nat. Neurosci. |
pmid:16116451
|
Marrs WR et al. |
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. |
2010 |
Nat. Neurosci. |
pmid:20657592
|
Hohmann AG et al. |
An endocannabinoid mechanism for stress-induced analgesia. |
2005 |
Nature |
pmid:15973410
|
Di Marzo V et al. |
Trick or treat from food endocannabinoids? |
1998 |
Nature |
pmid:9872309
|
Panikashvili D et al. |
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. |
2001 |
Nature |
pmid:11586361
|
Di Marzo V et al. |
Leptin-regulated endocannabinoids are involved in maintaining food intake. |
2001 |
Nature |
pmid:11298451
|
Wilson RI and Nicoll RA |
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. |
2001 |
Nature |
pmid:11279497
|
Stella N et al. |
A second endogenous cannabinoid that modulates long-term potentiation. |
1997 |
Nature |
pmid:9285589
|
Feliszek M et al. |
Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. |
2016 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:26984820
|
Schulte K et al. |
Cannabinoid CB1 receptor activation, pharmacological blockade, or genetic ablation affects the function of the muscarinic auto- and heteroreceptor. |
2012 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:22215206
|
Ameri A and Simmet T |
Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices. |
2000 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:10731038
|
Ilayan E et al. |
Do cannabinoids exhibit a tyramine-like effect? |
2013 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:23900610
|
Jergas B et al. |
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus. |
2014 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:24853577
|
Fernández-Suárez D et al. |
Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. |
2014 |
Neurobiol. Aging |
pmid:24973119
|
Arevalo-Martin A et al. |
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. |
2010 |
Neurobiol. Dis. |
pmid:20156559
|
Piomelli D et al. |
Endogenous cannabinoid signaling. |
1998 |
Neurobiol. Dis. |
pmid:9974178
|
Panikashvili D et al. |
The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. |
2006 |
Neurobiol. Dis. |
pmid:16364651
|
Vázquez C et al. |
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies. |
2015 |
Neurobiol. Dis. |
pmid:25917763
|
Avraham Y et al. |
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. |
2006 |
Neurobiol. Dis. |
pmid:16102970
|
Garcia-Ovejero D et al. |
The endocannabinoid system is modulated in response to spinal cord injury in rats. |
2009 |
Neurobiol. Dis. |
pmid:18930143
|
Melis M et al. |
Protective activation of the endocannabinoid system during ischemia in dopamine neurons. |
2006 |
Neurobiol. Dis. |
pmid:16762556
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Duan Y et al. |
Inhibition of [3H]batrachotoxinin A-20alpha-benzoate binding to sodium channels and sodium channel function by endocannabinoids. |
2008 |
Neurochem. Int. |
pmid:17888543
|
Bardell TK and Barker EL |
Activation of TRPC6 channels promotes endocannabinoid biosynthesis in neuronal CAD cells. |
2010 |
Neurochem. Int. |
pmid:20466028
|
Sang N et al. |
Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway. |
2010 |
Neurochem. Int. |
pmid:20064571
|
Best AR and Regehr WG |
Identification of the synthetic pathway producing the endocannabinoid that mediates the bulk of retrograde signaling in the brain. |
2010 |
Neuron |
pmid:20159441
|
Oleson EB et al. |
Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum. |
2012 |
Neuron |
pmid:22284189
|
Safo PK and Regehr WG |
Endocannabinoids control the induction of cerebellar LTD. |
2005 |
Neuron |
pmid:16301180
|
Gantz SC and Bean BP |
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid-Dependent Lipid Signaling. |
2017 |
Neuron |
pmid:28262417
|
Eroli F et al. |
Differential neuromodulatory role of endocannabinoids in the rodent trigeminal sensory ganglion and cerebral cortex relevant to pain processing. |
2018 |
Neuropharmacology |
pmid:29225040
|
Walentiny DM et al. |
Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. |
2015 |
Neuropharmacology |
pmid:25698527
|
Kortleven C et al. |
Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. |
2012 |
Neuropharmacology |
pmid:22884466
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Pasquarelli N et al. |
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue. |
2015 |
Neuropharmacology |
pmid:25497453
|
Chiu CQ and Castillo PE |
Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. |
2008 |
Neuropharmacology |
pmid:17706254
|
Morena M et al. |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. |
2016 |
Neuropharmacology |
pmid:27553121
|
Vellani V et al. |
Functional lipidomics. Calcium-independent activation of endocannabinoid/endovanilloid lipid signalling in sensory neurons by protein kinases C and A and thrombin. |
2008 |
Neuropharmacology |
pmid:18329052
|
Darmani NA et al. |
Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. |
2005 |
Neuropharmacology |
pmid:15921709
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Wilkerson JL et al. |
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. |
2017 |
Neuropharmacology |
pmid:27890602
|